Catherine Nigro, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19 School Rd, Holderness, NH 03245 Phone: 603-536-2538 |
News Archive
Lawmakers have focused a great deal of attention on alleviating the opioid public health crisis, while at the same time addressing across-the-board concerns regarding affordability of healthcare.
A new multi-targeted anticancer drug called SU11248 has shown very promising results in the treatment for metastatic renal cell cancer, one of the most chemotherapy resistant of all cancers.
Drs. Katerina Politi, Harold Varmus and colleagues at the Memorial Sloan Kettering Cancer Center in New York have developed a novel animal model of lung adenocarcinoma that will be of great use in testing the efficacy of targeted therapies against human lung cancer.
Decisions to withdraw life support treatments in critically ill patients with severe brain injury are complicated, are based on many factors, and are usually made by critical care physicians and families in the intensive care unit.
In a study published in Current Biology, scientists from the University of Rochester Medical Center, Marquette University and Oberlin College discovered a new way in which calcium signaling may be controlled. Study authors say their findings define a mechanism for regulating calcium signaling that has never been recognized before and should be of great help to the thousands of scientists who study the extremely important role of calcium signaling in health and disease.
› Verified 7 days ago